NO179909C - Analogifremgangsmåte for fremstilling av terapeutisk avtive 6-substituerte purinylpiperazinderivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk avtive 6-substituerte purinylpiperazinderivater

Info

Publication number
NO179909C
NO179909C NO911973A NO911973A NO179909C NO 179909 C NO179909 C NO 179909C NO 911973 A NO911973 A NO 911973A NO 911973 A NO911973 A NO 911973A NO 179909 C NO179909 C NO 179909C
Authority
NO
Norway
Prior art keywords
purinylpiperazine
derivatives
substituted
preparation
therapeutically effective
Prior art date
Application number
NO911973A
Other languages
English (en)
Norwegian (no)
Other versions
NO911973D0 (no
NO911973L (no
NO179909B (no
Inventor
Zoltan G Hajos
Jeffery B Press
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO911973D0 publication Critical patent/NO911973D0/no
Publication of NO911973L publication Critical patent/NO911973L/no
Publication of NO179909B publication Critical patent/NO179909B/no
Publication of NO179909C publication Critical patent/NO179909C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36Sulfur atom
    • C07D473/38Sulfur atom attached in position 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO911973A 1990-05-23 1991-05-22 Analogifremgangsmåte for fremstilling av terapeutisk avtive 6-substituerte purinylpiperazinderivater NO179909C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52762590A 1990-05-23 1990-05-23

Publications (4)

Publication Number Publication Date
NO911973D0 NO911973D0 (no) 1991-05-22
NO911973L NO911973L (no) 1991-11-25
NO179909B NO179909B (no) 1996-09-30
NO179909C true NO179909C (no) 1997-01-08

Family

ID=24102273

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911973A NO179909C (no) 1990-05-23 1991-05-22 Analogifremgangsmåte for fremstilling av terapeutisk avtive 6-substituerte purinylpiperazinderivater

Country Status (17)

Country Link
EP (1) EP0458618A1 (fi)
JP (1) JPH04226986A (fi)
KR (1) KR910020011A (fi)
CN (1) CN1031642C (fi)
AU (1) AU636034B2 (fi)
CA (1) CA2042944A1 (fi)
FI (1) FI912486A (fi)
HU (1) HUT57768A (fi)
IE (1) IE911751A1 (fi)
IL (1) IL98224A (fi)
MY (1) MY106167A (fi)
NO (1) NO179909C (fi)
NZ (1) NZ238122A (fi)
PT (1) PT97741B (fi)
TN (1) TNSN91037A1 (fi)
TW (1) TW211012B (fi)
ZA (1) ZA913880B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU648070B2 (en) * 1990-04-23 1994-04-14 Ortho Pharmaceutical Corporation Process for preparing optically active isomers of 6-substituted purinyl piperazine derivatives
JPH05255089A (ja) * 1991-12-18 1993-10-05 Sanwa Kagaku Kenkyusho Co Ltd 抗ウイルス剤
CA2294244A1 (en) * 1997-07-12 1999-01-21 Cancer Research Campaign Technology Limited Cyclin dependent kinase inhibiting purine derivatives
US20080039321A1 (en) * 2004-05-12 2008-02-14 Bastiaans Henricus M Plant Growth Regulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2334009A1 (de) * 1973-07-04 1975-01-23 Boehringer Mannheim Gmbh Purin-derivate sowie verfahren zu ihrer herstellung
DE3703633A1 (de) * 1986-02-14 1987-08-20 Sandoz Ag Purin-derivate, ihre herstellung und sie enthaltende arzneimittel
US4876257A (en) * 1988-03-03 1989-10-24 Ortho Pharmaceutical Corporation 6-Substituted purinyl piperazine derivatives useful as cardiotonic and antiarrhythmic agents

Also Published As

Publication number Publication date
FI912486A0 (fi) 1991-05-22
NO911973D0 (no) 1991-05-22
CN1031642C (zh) 1996-04-24
NZ238122A (en) 1994-01-26
NO911973L (no) 1991-11-25
ZA913880B (en) 1993-01-27
PT97741A (pt) 1992-02-28
JPH04226986A (ja) 1992-08-17
EP0458618A1 (en) 1991-11-27
IE911751A1 (en) 1991-12-04
CA2042944A1 (en) 1991-11-24
MY106167A (en) 1995-03-31
HUT57768A (en) 1991-12-30
FI912486A (fi) 1991-11-24
NO179909B (no) 1996-09-30
PT97741B (pt) 1998-10-30
CN1057463A (zh) 1992-01-01
AU636034B2 (en) 1993-04-08
IL98224A (en) 1995-07-31
TW211012B (fi) 1993-08-11
IL98224A0 (en) 1992-06-21
TNSN91037A1 (fr) 1992-10-25
KR910020011A (ko) 1991-12-19
AU7723391A (en) 1991-11-28

Similar Documents

Publication Publication Date Title
FI905941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI104170B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi
NO914825L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme alfa-oxoacetamider
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
NO179283C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO178543C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater
NO175528C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater
NO912797D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme karbostirilderivater.
FI98461B (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
FI911701A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
NO179517C (no) Fremgangsmåte for fremstilling av 8-klorkinolonderivater
NO179909C (no) Analogifremgangsmåte for fremstilling av terapeutisk avtive 6-substituerte purinylpiperazinderivater
NO914985D0 (no) Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater
NO302416B1 (no) Fremgangsmåte for fremstilling av pergolid
NO177710C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive slektede analoger
NO903397L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd.
NO914452D0 (no) Fremgangsmaate for fremstilling av isokinolinderivater
NO174196C (no) Fremgangsmåte for fremstilling av omega-decenol
NO177568C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive selenofenderivater
FI97885B (fi) Menetelmä terapeuttisesti aktiivisten nojirimysiinijohdannaisten valmistamiseksi
NO963084L (no) Fremgangsmåte for fremstilling av pyrrolidinyl-acetamidderivater
NO950203D0 (no) Fremgangsmåte for fremstilling av propargylazetidion-forbindelser
FI942927A (fi) Menetelmä terapeuttisesti käyttökelpoisten tetrahydronaftaleenijohdannaisten valmistamiseksi